Ethionamide adverse reactions: Difference between revisions

Jump to navigation Jump to search
No edit summary
mNo edit summary
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Ethionamide}}
{{Ethionamide}}
{{CMG}} ; {{AE}} {{chetan}}
{{CMG}}; {{AE}} {{chetan}}


 
==Adverse Reactions==
==Adverse Reactions===


===Gastrointestinal===
===Gastrointestinal===
Line 13: Line 12:


===Hepatic===
===Hepatic===
Transient increases in serum bilirubin, SGOT, SGPT; Hepatitis (with or without jaundice).
Transient increases in serum [[bilirubin]], [[SGOT]], [[SGPT]]. [[Hepatitis]] (with or without [[jaundice]]).


===Other===
===Other===

Latest revision as of 03:00, 31 December 2013

Ethionamide
TRECATOR® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]

Adverse Reactions

Gastrointestinal

The most common side effects of ethionamide are gastrointestinal disturbances including nausea, vomiting, diarrhea, abdominal pain, excessive salivation, metallic taste, stomatitis, anorexia and weight loss. Adverse gastrointestinal effects appear to be dose related, with approximately 50% of patients unable to tolerate 1 gm as a single dose. Gastrointestinal effects may be minimized by decreasing dosage, by changing the time of drug administration, or by the concurrent administration of an antiemetic agent.

Nervous System

Psychotic disturbances (including mental depression), drowsiness, dizziness, restlessness, headache, and postural hypotension have been reported with ethionamide. Rare reports of peripheral neuritis, optic neuritis, diplopia, blurred vision, and a pellagra-like syndrome also have been reported. Concurrent administration of pyridoxine has been recommended to prevent or relieve neurotoxic effects.

Hepatic

Transient increases in serum bilirubin, SGOT, SGPT. Hepatitis (with or without jaundice).

Other

Hypersensitivity reactions including rash, photosensitivity, thrombocytopenia and purpura have been reported rarely. Hypoglycemia, hypothyroidism, gynecomastia, impotence, and acne also have occurred. The management of patients with diabetes mellitus may become more difficult in those receiving ethionamide.[1]

References

  1. "TRECATOR (ETHIONAMIDE) TABLET, FILM COATED [WYETH PHARMACEUTICALS COMPANY, A SUBSIDIARY OF PFIZER INC.]". Text " accessdate " ignored (help)

Adapted from the FDA Package Insert.